Results 101 to 110 of about 8,720 (195)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia

, 2012
Background and aim Procedural failure and untoward clinical outcomes after surgery remain problematic in critical limb ischemia (CLI) patients. This study tested a clopidogrel-cilostazol combination treatment compared with either treatment alone in ...
Tsai Tzu-Hsien, Lin Kun-Chen, Yen Chia-Hung, Yip Hon-Kan, Sheu Jiunn-Jye, Chen Yung-Lung, Chua Sarah, Yang Jenq-Lin, Sun Cheuk-Kwan, Tsai Ching-Yen, Leu Steve, Chang Hsueh-Wen   +11 more
core   +1 more source

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

Medical Devices: Evidence and Research, 2011
Ichiro Ikushima1, Kazuchika Yonenaga1, Hironao Iwakiri2, Hideki Nagoshi2, Haruhito Kumagai2, Yasuyuki Yamashita31Department of Radiology, 2Department of Cardiology, Miyakonojo Medical Association Hospital, Miyakonojo, Japan; 3Department of Diagnostic ...
Ikushima I, Yonenaga K, Iwakiri H, Nagoshi H, Kumagai H, Yamashita Y   +5 more
doaj  

Spectrophotometric Determination of Cilostazol in Tablet Dosage Form

, 2011
Purpose: To develop simple, rapid and selective spectrophotometric methods for the determination of cilostazol in tablet dosage form. Methods: Cilostazol was dissolved in 50 % methanol and its absorbance was scanned by ultraviolet (UV) spectrophotometry.
Basniwal, Pawan Kumar, Kumar, Vinesh, Shrivastava, Prabhat Kumar, Jain, Deepti   +3 more
core  

Cilostazol w leczeniu niedokrwienia kończyn dolnych [PDF]

, 2014
Cilostazol is a selective, reversible inhibitor of phosphodiesterase type 3, which inhibits platelet aggregation and exerts a vasodilation effect. These therapeutic properties justified its use in the conservative treatment of chronic lower limb ischemia.
Chudek, Jerzy, Ziaja, Damian
core  

Cilostazol Treatment for Intracerebral Hemorrhage: Targeting Dural Lymphatics. [PDF]

Stroke
Lan CK, Chen WR, Hsieh YC, Lin TY, Hsu SC, Jiang ZR, Chen SP, Jiang D, McCullough LD, Aronowski J, Tsai LK, Tsai HH, Chang CF.   +12 more
europepmc   +1 more source

Cilostazol and Functional Outcomes in Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Analysis. [PDF]

J Clin Med
Kikuchi J, Otsu Y, Kajiwara S, Orito K, Hirohata M, Sakata K, Takizawa K, Tanaka Y, Chin M, Kurita H, Hirayama A, Irie K, Suyama K, Nakahara I, Horie N, Morioka M, Ikawa F.   +16 more
europepmc   +1 more source

Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China. [PDF]

EClinicalMedicine
Wang Y, Sui Y, Qu H, Pan Y, Guan L, Qiu B, Liu L, Miao Z, Wang L, Bath PM, Johnston SC, Wang X, Chen G, Yang Q, Wu J, Ren L, Huo X, Li S, Li Z, Zhao X, Wang Y, Liao X, Wang Y, FUTURE Investigators.   +23 more
europepmc   +1 more source

Ion Channel-Targeting Modulators in Glioma: Pharmacological Advances and Therapeutic Perspectives. [PDF]

Int J Mol Sci
Wu SN, Lin SC, Liutkevičienė R.
europepmc   +1 more source

Effects of intravenous human albumin, enteral cilostazol, and combination therapy on the reduction of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. [PDF]

Front Neurol
Qureshi AI, Raza H, Beall J, Gajewski B, Martin RH, Suarez JI.   +5 more
europepmc   +1 more source

Comparative effectiveness of dual antiplatelet therapy after revascularization in diabetes and chronic limb-threatening ischemia: a target trial emulation study. [PDF]

Cardiovasc Diabetol
Lin CW, Liu PH, Lin CH, Huang CH, Hung SY, Chen IW, Chen YC, Huang YY.   +7 more
europepmc   +1 more source